News

10/03/2022

Researchers propose a new biomarker that may be key in the diagnosis of psychotic outbreaks

Researchers from the Research Institute of the Hospital de Sant Pau – IIB Sant Pan, the Hospital Clínic-IDIBAPS and the CIBERER, propose a biomarker that could accurately and non-invasively identif...

09/02/2022

Scientists discover a micro-RNA that can promote the development of atherosclerosis in patients with coronary disease

A study by IIB Sant Pau, CIBERDEM and IDIBELL shows that miR-125b affects the ability of HDL lipoproteins to extract colesterol from macrophages and smooth muscle cells of the arterial wall, accelerat...

04/02/2022

Nanoligent, Sant Pau’s spin-off, raises €1M in series seed financing

Nanoligent SL, a biotech company spin-off of the Sant Pau Research Institute and Universitat Autònoma de Barcelona specialized in the development of nanotechnology-based cancer treatments, today anno...

20/12/2021

Patients with stroke and COVID-19 have more severe strokes and higher mortality

A multicenter study, led by neurologists at the Research Instituto of the Sant Pau Hospital and with the participation of the main Catalan hospitals, analyses the relationship between stroke and COVID...

24/11/2021

The UAB – IR Sant Pau Joint Research Unit in Genomic Medicine begins its activity

The Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, the Autonomous University of Barcelona and the Private Foundation Hospital de la Santa Creu i Sant Pau make possible ...